<p>LENSAR, Inc.（纳斯达克代码：LNSR - 获取免费报告）在周四的午盘交易中上涨了 0.6%。该股最高交易价为 12.66 美元，最后交易价为 12.28 美元。在午盘交易中，约有 113,489 股成交，较日均成交量 31,360 股增加了 262%。该股此前收盘价为 12.21 美元。</p>
<h2>华尔街分析师观点</h2>
<p>几家券商最近对 LNSR 发表了看法。Weiss Ratings 在 1 月 22 日的研究报告中重申了对 LENSAR 股票的 “卖出（d-）” 评级。Wall Street Zen 在 11 月 28 日的研究报告中将 LENSAR 股票的评级上调至 “持有”。两位股票研究分析师对该股给予了持有评级，一位分析师则对该股给予了卖出评级。根据 MarketBeat 的数据，该公司的共识评级为 “减持”，共识目标价为 15.00 美元。</p>
<p><strong>查看我们最新的 LNSR 股票报告</strong></p>
<h2>LENSAR 股票表现</h2>
<p>该公司的 50 日移动平均价格为 11.77 美元，200 日移动平均价格为 11.95 美元。该公司的市值为 1.4668 亿美元，市盈率为-2.80，贝塔值为 0.69。</p>
<p>LENSAR（纳斯达克代码：LNSR - 获取免费报告）最近在 11 月 6 日发布了季度财报。该公司报告季度每股收益为（0.31 美元），低于分析师共识预期的（0.08 美元）23 美分。该公司在本季度的收入为 1432 万美元，而分析师预期为 1775 万美元。</p>
<h2>LENSAR 的机构交易</h2>
<p>几家机构投资者最近增持或减持了对该公司的股份。Brandes Investment Partners LP 在第二季度将其在 LENSAR 的持股比例提高了 3.5%。Brandes Investment Partners LP 目前拥有 563,581 股该公司的股票，价值 742.2 万美元，此前在上个季度又购买了 18,894 股。Vanguard Group Inc.在第三季度将其在 LENSAR 的持股比例提高了 0.3%。Vanguard Group Inc.目前拥有 507,603 股该公司的股票，价值 626.9 万美元，此前在该期间又收购了 1,446 股。Groupe la Francaise 在第二季度将其在 LENSAR 的持股比例提高了 99.5%。Groupe la Francaise 目前拥有 251,400 股该公司的股票，价值 331.1 万美元，此前在上个季度又收购了 125,400 股。Geode Capital Management LLC 在第二季度将其在 LENSAR 的持股比例提高了 103.9%。Geode Capital Management LLC 目前拥有 219,373 股该公司的股票，价值 289 万美元，此前在该期间又收购了 111,802 股。最后，Credit Industriel ET Commercial 在第二季度将其在 LENSAR 的持股比例提高了 98.4%。Credit Industriel ET Commercial 目前拥有 168,600 股该公司的股票，价值 222 万美元，此前在该期间又收购了 83,600 股。机构投资者持有该公司 40.15% 的股份。</p>
<h2>关于 LENSAR</h2>
<p>（获取免费报告）</p>
<p>LENSAR, Inc.总部位于佛罗里达州奥兰多，是一家专注于眼科手术先进激光系统的医疗技术公司。其旗舰产品 LENSAR 激光系统结合了专有的三维成像技术和精确引导的飞秒激光传输，以执行白内障手术中的关键步骤，包括囊膜切开、晶状体碎裂和角膜切口。</p>
<p>LENSAR 成立于 2005 年，专注于提高白内障治疗中的手术精确度和患者结果的研究与开发。</p>
<h2>精选故事</h2>
<ul>
<li>我们更看好的五只股票比 LENSAR 更好</li>
<li>用这 4 个简单步骤 “防止” 你的银行账户受到美联储影响</li>
<li>何时购买黄金（从数学角度看）</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>曝光：“29% 账户”</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 LENSAR 吗？</h2>
<p>在你考虑 LENSAR 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 LENSAR 并不在名单上。</p>
<p>虽然 LENSAR 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美国医药设备 ETF - iShares

标普健康医疗设备 ETF - SPDR

LNSR

<p>LENSAR（纳斯达克代码：LNSR）股票上涨 0.6%，至 12.28 美元，交易量增加了 262%。分析师的评级各不相同，Weiss Ratings 维持 “卖出” 评级，而 Wall Street Zen 则上调至 “持有”。该公司报告的季度每股收益为（$0.31），未达到预期，收入为 1432 万美元，低于预期。机构投资者持有 40.15% 的股份，其中 Brandes Investment Partners 和 Vanguard Group 的持股显著增加。LENSAR 专注于眼科手术的先进激光系统，致力于提高白内障治疗的手术准确性</p>

<p>LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) rose 0.6% during mid-day trading on Thursday . The stock traded as high as $12.66 and last traded at $12.28. Approximately 113,489 shares changed hands during mid-day trading, an increase of 262% from the average daily volume of 31,360 shares. The stock had previously closed at $12.21.</p>
<div class="lb-trans"><p>LENSAR, Inc.（纳斯达克代码：LNSR - 获取免费报告）在周四的午盘交易中上涨了 0.6%。该股最高交易价为 12.66 美元，最后交易价为 12.28 美元。在午盘交易中，约有 113,489 股成交，较日均成交量 31,360 股增加了 262%。该股此前收盘价为 12.21 美元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Several brokerages have recently weighed in on LNSR. Weiss Ratings reaffirmed a &#34;sell (d-)&#34; rating on shares of LENSAR in a research report on Thursday, January 22nd. Wall Street Zen upgraded shares of LENSAR to a &#34;hold&#34; rating in a research note on Friday, November 28th. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of &#34;Reduce&#34; and a consensus price target of $15.00.</p>
<div class="lb-trans"><p>几家券商最近对 LNSR 发表了看法。Weiss Ratings 在 1 月 22 日的研究报告中重申了对 LENSAR 股票的 “卖出（d-）” 评级。Wall Street Zen 在 11 月 28 日的研究报告中将 LENSAR 股票的评级上调至 “持有”。两位股票研究分析师对该股给予了持有评级，一位分析师则对该股给予了卖出评级。根据 MarketBeat 的数据，该公司的共识评级为 “减持”，共识目标价为 15.00 美元。</p>
</div><p><strong>View Our Latest Stock Report on LNSR</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 LNSR 股票报告</strong></p>
</div><h2>LENSAR Stock Performance</h2>
<div class="lb-trans"><h2>LENSAR 股票表现</h2>
</div><p>The business's 50 day moving average price is $11.77 and its 200-day moving average price is $11.95. The firm has a market cap of $146.68 million, a price-to-earnings ratio of -2.80 and a beta of 0.69.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均价格为 11.77 美元，200 日移动平均价格为 11.95 美元。该公司的市值为 1.4668 亿美元，市盈率为-2.80，贝塔值为 0.69。</p>
</div><p>LENSAR (NASDAQ:LNSR - Get Free Report) last posted its quarterly earnings results on Thursday, November 6th. The company reported ($0.31) EPS for the quarter, missing analysts' consensus estimates of ($0.08) by ($0.23). The company had revenue of $14.32 million during the quarter, compared to analyst estimates of $17.75 million.</p>
<div class="lb-trans"><p>LENSAR（纳斯达克代码：LNSR - 获取免费报告）最近在 11 月 6 日发布了季度财报。该公司报告季度每股收益为（0.31 美元），低于分析师共识预期的（0.08 美元）23 美分。该公司在本季度的收入为 1432 万美元，而分析师预期为 1775 万美元。</p>
</div><h2>Institutional Trading of LENSAR</h2>
<div class="lb-trans"><h2>LENSAR 的机构交易</h2>
</div><p>Several institutional investors have recently added to or reduced their stakes in the business. Brandes Investment Partners LP lifted its position in shares of LENSAR by 3.5% in the 2nd quarter. Brandes Investment Partners LP now owns 563,581 shares of the company's stock worth $7,422,000 after buying an additional 18,894 shares during the last quarter. Vanguard Group Inc. raised its stake in LENSAR by 0.3% during the third quarter. Vanguard Group Inc. now owns 507,603 shares of the company's stock worth $6,269,000 after acquiring an additional 1,446 shares during the period. Groupe la Francaise lifted its holdings in LENSAR by 99.5% in the second quarter. Groupe la Francaise now owns 251,400 shares of the company's stock worth $3,311,000 after acquiring an additional 125,400 shares during the last quarter. Geode Capital Management LLC boosted its stake in LENSAR by 103.9% in the second quarter. Geode Capital Management LLC now owns 219,373 shares of the company's stock valued at $2,890,000 after acquiring an additional 111,802 shares during the period. Finally, Credit Industriel ET Commercial boosted its stake in LENSAR by 98.4% in the second quarter. Credit Industriel ET Commercial now owns 168,600 shares of the company's stock valued at $2,220,000 after acquiring an additional 83,600 shares during the period. Institutional investors own 40.15% of the company's stock.</p>
<div class="lb-trans"><p>几家机构投资者最近增持或减持了对该公司的股份。Brandes Investment Partners LP 在第二季度将其在 LENSAR 的持股比例提高了 3.5%。Brandes Investment Partners LP 目前拥有 563,581 股该公司的股票，价值 742.2 万美元，此前在上个季度又购买了 18,894 股。Vanguard Group Inc.在第三季度将其在 LENSAR 的持股比例提高了 0.3%。Vanguard Group Inc.目前拥有 507,603 股该公司的股票，价值 626.9 万美元，此前在该期间又收购了 1,446 股。Groupe la Francaise 在第二季度将其在 LENSAR 的持股比例提高了 99.5%。Groupe la Francaise 目前拥有 251,400 股该公司的股票，价值 331.1 万美元，此前在上个季度又收购了 125,400 股。Geode Capital Management LLC 在第二季度将其在 LENSAR 的持股比例提高了 103.9%。Geode Capital Management LLC 目前拥有 219,373 股该公司的股票，价值 289 万美元，此前在该期间又收购了 111,802 股。最后，Credit Industriel ET Commercial 在第二季度将其在 LENSAR 的持股比例提高了 98.4%。Credit Industriel ET Commercial 目前拥有 168,600 股该公司的股票，价值 222 万美元，此前在该期间又收购了 83,600 股。机构投资者持有该公司 40.15% 的股份。</p>
</div><h2>About LENSAR</h2>
<div class="lb-trans"><h2>关于 LENSAR</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.</p>
<div class="lb-trans"><p>LENSAR, Inc.总部位于佛罗里达州奥兰多，是一家专注于眼科手术先进激光系统的医疗技术公司。其旗舰产品 LENSAR 激光系统结合了专有的三维成像技术和精确引导的飞秒激光传输，以执行白内障手术中的关键步骤，包括囊膜切开、晶状体碎裂和角膜切口。</p>
</div><p>Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.</p>
<div class="lb-trans"><p>LENSAR 成立于 2005 年，专注于提高白内障治疗中的手术精确度和患者结果的研究与开发。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than LENSAR</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
<li>When to buy gold (mathematically)</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
<li>EXPOSED: The “29% Account”</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 LENSAR 更好</li>
<li>用这 4 个简单步骤 “防止” 你的银行账户受到美联储影响</li>
<li>何时购买黄金（从数学角度看）</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>曝光：“29% 账户”</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in LENSAR Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 LENSAR 吗？</h2>
</div><p>Before you consider LENSAR, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 LENSAR 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LENSAR wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 LENSAR 并不在名单上。</p>
</div><p>While LENSAR currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 LENSAR 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

LENSAR（纳斯达克代码：LNSR）股价上涨 0.6% - 以下是原因